
Psoriasis
- Tofacitinib May Improve Enthesitis Among Patients With Psoriatic Arthritis
- Patients With Psoriasis-Related Multimorbidity Require Multidisciplinary Management Approach
- Anti-IL-17 Molecules a Beneficial Option for Treating Generalized Pustular Psoriasis
- Coronary Microvascular Dysfunction Identified in 31.5% With Psoriasis
- Brodalumab May Reduce Symptoms of Depression and Anxiety in GPP
- Model Reliably Predicts Risk of Developing Psoriatic Arthritis Among Patients With Psoriasis
- High-Quality Evidence Lacking for Nondrug Treatments in Psoriatic Arthritis
- Psoriasis Raises Retinal Vein Occlusion Risk For Those With Diabetic Retinopathy
- Psoriasis May Be Underdiagnosed Among Patients With Axial Spondyloarthritis
- Clinician Education is Crucial for the Early Recognition of Psoriatic Arthritis
- Depressive Symptoms Common Among Patients With axSpA and PsA
- New Study Suggests Patients With GPP Have Significantly Elevated Mortality Rate
Clinical Tools
Powered by
Powered by 